| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters M Feuerer, L Herrero, D Cipolletta, A Naaz, J Wong, A Nayer, J Lee, ... Nature medicine 15 (8), 930-939, 2009 | 2335 | 2009 |
| Effects of exercise training on subcutaneous and visceral adipose tissue in normal-and high-fat diet-fed rats KSC Gollisch, J Brandauer, N Jessen, T Toyoda, A Nayer, MF Hirshman, ... American Journal of Physiology-Endocrinology and Metabolism 297 (2), E495-E504, 2009 | 296 | 2009 |
| Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice MM Altintas, A Azad, B Nayer, G Contreras, J Zaias, C Faul, J Reiser, ... Journal of lipid research 52 (3), 480-488, 2011 | 237 | 2011 |
| Inflammation and adipose tissue macrophages in lipodystrophic mice L Herrero, H Shapiro, A Nayer, J Lee, SE Shoelson Proceedings of the National Academy of Sciences 107 (1), 240-245, 2010 | 200 | 2010 |
| Catastrophic antiphospholipid syndrome: a clinical review A Nayer, LM Ortega Journal of nephropathology 3 (1), 9, 2014 | 168 | 2014 |
| Flock worker's lung: chronic interstitial lung disease in the nylon flocking industry DG Kern, RS Crausman, KTH Durand, A Nayer, C Kuhn III Annals of internal medicine 129 (4), 261-272, 1998 | 162 | 1998 |
| Small molecule–mediated activation of the integrin CD11b/CD18 reduces inflammatory disease D Maiguel, MH Faridi, C Wei, Y Kuwano, KM Balla, D Hernandez, ... Science signaling 4 (189), ra57-ra57, 2011 | 140 | 2011 |
| Dengue-associated kidney disease KJ Lizarraga, A Nayer Journal of nephropathology 3 (2), 57, 2014 | 127 | 2014 |
| The effects of vitamin D on the renin-angiotensin system S Ajabshir, A Asif, A Nayer Journal of nephropathology 3 (2), 41, 2014 | 107 | 2014 |
| The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients I Rodríguez-Pintó, G Espinosa, D Erkan, Y Shoenfeld, R Cervera Rheumatology 57 (7), 1264-1270, 2018 | 93 | 2018 |
| Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab A Asif, A Nayer, CS Haas Journal of nephrology 30, 347-362, 2017 | 91 | 2017 |
| Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease V Peev, A Nayer, G Contreras Current opinion in lipidology 25 (1), 54-60, 2014 | 90 | 2014 |
| Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice MM Altintas, MA Rossetti, B Nayer, A Puig, P Zagallo, LM Ortega, ... Lipids in health and disease 10, 1-12, 2011 | 66 | 2011 |
| The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy RO Mathew, A Nayer, A Asif Journal of the American Society of Hypertension 10 (4), 352-359, 2016 | 57 | 2016 |
| Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloimmune responses in vivo AD Salama, X Yuan, A Nayer, A Chandraker, M Inobe, T Uede, ... American Journal of Transplantation 3 (4), 390-395, 2003 | 45 | 2003 |
| Hypertension in the African American population: a succinct look at its epidemiology, pathogenesis, and therapy LM Ortega, E Sedki, A Nayer Nefrologia 35 (2), 139-145, 2015 | 44 | 2015 |
| Fat Treg cells: a liaison between the immune and metabolic systems M Feuerer, L Herrero, D Cipolletta, A Naaz, J Wong, A Nayer, J Lee, ... Nature medicine 15 (8), 930, 2009 | 39 | 2009 |
| Atypical Hemolytic–Uremic Syndrome: A Clinical Review A Nayer, A Asif American journal of therapeutics 23 (1), e151-e158, 2016 | 38 | 2016 |
| Crystal-induced acute kidney injury due to ciprofloxacin M Khan, LM Ortega, N Bagwan, A Nayer Journal of nephropathology 4 (1), 29, 2015 | 37 | 2015 |
| Comparison of mortality of ESRD patients with lupus by initial dialysis modality G Contreras, J Pagan, R Chokshi, S Virmani, JM Diego, P Byers, ... Clinical journal of the American Society of Nephrology 9 (11), 1949-1956, 2014 | 34 | 2014 |
Mehmet Mete AltintasAssociate Professor of Medicine, Rush UniversityVerified email at rush.edu
